Marsh & McLennan Companies (MMC)
(Delayed Data from NYSE)
$218.91 USD
+0.44 (0.20%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $218.81 -0.10 (-0.05%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$218.91 USD
+0.44 (0.20%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $218.81 -0.10 (-0.05%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Zacks News
4 Insurance Brokers Poised for a Bull Run in the Second Half
by Srijita Guha
Strategic initiatives, uptake of technology and rising demand for insurance products are expected to aid insurance brokers like AON, WLTW, MMC and BRO in second-half 2021.
Marsh & McLennan (MMC) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Marsh & McLennan (MMC) could produce exceptional returns because of its solid growth attributes.
The Zacks Analyst Blog Highlights: American International Group, Cincinnati Financial Corp., Marsh & McLennan, MetLife and Aflac
by Zacks Equity Research
The Zacks Analyst Blog Highlights: American International Group, Cincinnati Financial Corp., Marsh & McLennan, MetLife and Aflac
The Zacks Analyst Blog Highlights: Nasdaq, Paychex, Marsh & McLennan, Chubb and Republic Services
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nasdaq, Paychex, Marsh & McLennan, Chubb and Republic Services
Top 5 Picks From S&P 500's Best Sector in the Past Month
by Nalak Das
We have narrowed down our search to five large-cap insurers that have strong growth potential for the rest of 2021. These are: AFL, AIG, MMC, MET and CINF.
Top 5 High-Flying Low-Beta Stocks to Counter Market Volatility
by Nalak Das
It will be prudent to invest in low-beta stocks with a favorable Zacks Rank that have performed impressively in the past three months. These are MMC, NDAQ, CB, PAYX and RSG.
Aon (AON) Hits 52 Week High: More Room for Upside Left?
by Zacks Equity Research
Aon's (AON) shares rally as investors get optimistic about its latest strategic initiatives and solid second-quarter results.
Arthur J. Gallagher (AJG) to Buy Willis Re for $3.25B in Cash
by Zacks Equity Research
Arthur J. Gallagher's (AJG) pending buyout of Willis Re will position Gallagher Re as one of the top three reinsurance brokers.
Why Should You Add Marsh & McLennan (MMC) to Your Portfolio?
by Zacks Equity Research
Riding high on second-quarter results and strategic initiatives, Marsh & McLennan (MMC) holds enough potential to reap benefits for investors.
Bet on Top-Ranked Sectors With These ETFs & Stocks
by Sweta Killa
Thanks to solid corporate earnings and a fresh large infrastructure bill, the Wall Street bulls are charging higher.
Willis Towers (WLTW) Q2 Earnings & Revenues Top, Dividend Up
by Zacks Equity Research
Willis Towers (WLTW) Q2 results reflect broad-based revenue growth, continued margin expansion, and significant bottom line growth
The Zacks Analyst Blog Highlights: Nike, General Motors, Marsh & McLennan, Capital One Financial and Intuitive Surgical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nike, General Motors, Marsh & McLennan, Capital One Financial and Intuitive Surgical
U.S. Economy Exceeds Pre-Pandemic Level: 5 Top Picks
by Nalak Das
We have narrowed down our search to five corporate giants that have seen positive earnings estimate revisions for 2021 within the last 7 days. These are: GM, NKE, MMC, ISRG and COF.
Willis Towers Watson (WLTW) and AON Merger Falls Apart
by Zacks Equity Research
Willis Towers (WLTW) and AON's merger falls apart as U.S. Department of Justice anticipates that the merger could threaten competition.
What Awaits Arthur J. Gallagher (AJG) This Earnings Season?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) Q2 results are likely to reflect strong EBITDAC growth, increase in covered lives and special project work as well as higher property and casualty rates.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Marsh & McLennan's (MMC) Q2 Earnings Beat, Rise Y/Y
by Zacks Equity Research
Marsh & McLennan's (MMC) Q2 earnings gain from better revenues at both its Risk and Insurance Services and Consulting segments.
Marsh & McLennan (MMC) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 23.24% and 12.87%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Why Marsh & McLennan (MMC) Might Surprise This Earnings Season
by Zacks Equity Research
Marsh & McLennan (MMC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in Store for Marsh & McLennan's (MMC) Q2 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) second-quarter results are likely to reflect better revenues and a solid contribution made by its Risk and Insurance Services as well as Consulting segments.
Marsh & McLennan (MMC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Marsh & McLennan (MMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
7 Insurers That Are Likely to Deliver Q2 Earnings Beat
by Tanuka De
Better pricing, exposure growth, redesigning of products and sturdy capital are expected to help AXS, NMIH, MET, ATH, VOYA, MMC, and AFL outperform Q2 earnings estimates.
Arthur J. Gallagher (AJG) Buys Rest of Edelweiss Shares
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires the residual interest in Edelweiss Gallagher to reinforce its footprint in India.
First American (FAF) Completes Buyout of Georgetown Title
by Zacks Equity Research
First American Financial (FAF) acquires Georgetown Title to expand its global footprint and enhance its title insurance business.
Arthur J. Gallagher (AJG) Announces Stellar Benefits Buyout
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires Stellar Benefits to boost its benefits capabilities throughout Northeastern Ohio.